What Is NMN? Benefits, NAD+ & Aging Research (2026)

Key Takeaways

What is NMN? Nicotinamide mononucleotide is a direct precursor to NAD+, a coenzyme required for 500+ enzymatic reactions including DNA repair, mitochondrial energy production, and sirtuin activation. Dr. Shin-ichiro Imai at Washington University School of Medicine characterized NAD+ decline as a hallmark of aging and identified NMN supplementation as the most direct route to restoring cellular NAD+ levels (Imai, 2014, Trends in Cell Biology). NMN supplements at 250–600 mg/day have demonstrated safety in multiple human trials, with the Yoshino 2021 RCT at Washington University confirming improved muscle insulin sensitivity as the first clinically significant metabolic outcome.

NMN (nicotinamide mononucleotide) is a naturally occurring molecule that your body converts into NAD+, a coenzyme required for over 500 enzymatic reactions, including energy production, DNA repair, and sirtuin activation. NAD+ levels decline measurably with age, and 12+ published human clinical trials now show that oral NMN supplementation reliably restores those levels. A January 2026 study in Nature Metabolism confirmed that NMN doubles circulating NAD+ within 14 days, matching NR and outperforming nicotinamide (Christen et al., 2026).

This guide breaks down what the published research demonstrates, where the science has gaps, and what it means if you're considering NMN supplementation.

NMN Benefits: What Is NMN and How Does It Work?

NMN (nicotinamide mononucleotide) is a direct precursor to NAD+, a coenzyme central to energy metabolism and DNA repair that declines with age. Your body converts NMN to NAD+ in one step. Supplementing raises blood NAD+, with human trials showing modest gains in endurance and metabolic markers.

Nicotinamide mononucleotide is a nucleotide derived from vitamin B3. Once ingested, the enzyme NMNAT converts it into NAD+, nicotinamide adenine dinucleotide, a coenzyme that participates in glycolysis, the TCA cycle, oxidative phosphorylation, and the activation of sirtuins (a family of proteins that regulate DNA repair, inflammation, and mitochondrial function).

Without adequate NAD+, those processes slow down. Mitochondrial output drops. DNA damage accumulates faster than repair enzymes can fix it. Inflammatory signaling ramps up, not dramatically, but steadily, in the background.

According to a 2023 review published in Advances in Nutrition, NAD+ concentrations in skin, blood, liver, muscle, and brain appear to decline with age, by some estimates, roughly 50% between ages 40 and 60 (Song et al., 2023). NMN supplementation offers a way to replenish that supply from the outside in.

Harvard geneticist David Sinclair, PhD, whose lab has published extensively on NAD+ biology, has described NAD+ decline as a central driver of age-related dysfunction, with NMN studied as one way to raise NAD+ levels and support the sirtuin enzymes that help protect cells against damage. Reported increases in blood NAD+ vary between studies, and the size and durability of the effect in humans remain under active investigation.

How Much Does NMN Actually Raise NAD+?

NMN reliably raises NAD+ in every published trial that measured it, though the magnitude varies with dose and duration. According to Igarashi et al. ( 2022, NPJ Aging ), 250 mg/day for 12 weeks increased whole-blood NAD+ approximately sixfold in 42 healthy men over 65.

According to Igarashi et al. (2022, NPJ Aging), 250 mg/day for 12 weeks increased whole-blood NAD+ approximately sixfold in 42 healthy men over 65. This was one of the first rigorous human studies to confirm what animal models had suggested for years.

Yi et al. (2023, GeroScience) tested three doses, 300, 600, and 900 mg/day, in 80 middle-aged adults over 60 days. NAD+ rose dose-dependently: roughly threefold at 300 mg, sixfold at 600 mg. The 600 mg and 900 mg groups also walked significantly farther in a six-minute test.

The most recent data comes from Christen et al. (2026, Nature Metabolism), a four-arm randomized trial in 65 healthy adults comparing 1,000 mg/day of NMN, NR, and nicotinamide against placebo over 14 days. Both NMN and NR doubled circulating NAD+. Nicotinamide did not. This is the first head-to-head comparison in humans.

What are NMN's evidence-backed benefits?

NMN's best-supported benefits are raising blood NAD+ and modest functional gains: better walking endurance, improved muscle insulin sensitivity in prediabetic women, and small strength changes. The effects are measurable on bloodwork rather than dramatic. Claims about reversing aging or skin go beyond what current human trials show.

1. Cellular Energy Production

NAD+ is essential for converting food into ATP, your cells' primary energy currency. Every step of glucose metabolism, from glycolysis through the electron transport chain, requires NAD+.

When NAD+ drops, mitochondrial output declines, not catastrophically, but enough that you feel it: slower recovery, less endurance, that vague sense of running on 70% capacity. According to Yoshino et al. (2018, Cell Metabolism), this is particularly relevant for tissues with high energy demands — skeletal muscle, the brain, and the heart.

2. Walking Speed and Muscle Function

According to Igarashi et al. (2022), 250 mg/day NMN for 12 weeks produced nominally significant improvements in gait speed and left-hand grip strength in men over 65. A 2024 systematic review of randomized controlled trials confirmed that NMN improved select physical performance parameters across multiple studies (Wen et al., 2024, Cureus).

Yi et al. (2023) reported that participants taking 600–900 mg/day walked significantly farther in the six-minute walking test at both day 30 and day 60. And Liao et al. (2021, JISSN) showed enhanced aerobic capacity in amateur runners, meaning the benefits aren't limited to the elderly.

3. Sleep Quality

According to Kim et al. (2022, Biomedical Research), 250 mg/day for 12 weeks in 108 adults over 65 reduced drowsiness when taken in the afternoon.

A separate 2022 Chinese trial in 80 adults with poor sleep found that NMN improved deep sleep ratio, REM sleep, and reduced nighttime awakenings, with a 65.5% response rate versus 27.6% for placebo. If you're already exploring magnesium glycinate for sleep or ashwagandha for sleep, NMN works through a completely different mechanism: NAD+ interacts directly with SIRT1 and the CLOCK/BMAL1 pathway; the molecular clock that governs your sleep-wake cycle.

4. Insulin Sensitivity

According to Yoshino et al. (2021, Science), a double-blind trial in 25 postmenopausal women with elevated blood sugar showed that 10 weeks of 250 mg/day NMN significantly improved muscle insulin sensitivity.

That's one of the strongest individual findings. But here's the counterweight, and we think you should see it. A 2024 meta-analysis of 12 studies with 513 participants found that while NMN consistently raised NAD+, most metabolic outcomes (fasting glucose, lipid profiles) were not significantly different from placebo (Zhang et al., 2025, Critical Reviews in Food Science and Nutrition). The researchers explicitly cautioned that "an exaggeration of the benefits of NMN supplementation may exist in the field." We'd rather you know that upfront than find out later.

5. Blood Pressure

A February 2026 systematic review and meta-analysis of randomized controlled trials found that NMN supplementation reduced diastolic blood pressure by an average of 2.15 mmHg, a modest but potentially meaningful reduction.

Katayoshi et al. (2023) separately found that 250 mg/day for 12 weeks reduced arterial stiffness markers in 34 adults aged 40–59. If you're interested in how other supplements may support cardiovascular markers, berberine's effects on cholesterol and blood sugar work through an entirely different pathway (AMPK activation rather than NAD+ restoration).

6. Gut Microbiome

The 2026 Nature Metabolism study by Christen et al. revealed something unexpected: NMN and NR both modulated gut bacteria to increase concentrations of short-chain fatty acids (SCFAs) — metabolites associated with a stronger gut barrier and reduced systemic inflammation.

The researchers also found evidence that gut bacteria convert NMN and NR into nicotinic acid (NA), a potent NAD+ booster, suggesting the microbiome plays a larger role in NAD+ metabolism than anyone anticipated. This is brand-new territory. One study. But it opens a line of inquiry that could reshape how we think about NAD+ precursor supplementation.

NMN vs NR, which is better?

Until January 2026, no human trial had directly compared NMN and NR in the same study. Christen et al. (Nature Metabolism) tested 1,000 mg/day each of NMN, NR, and nicotinamide against placebo for 14 days in 65 healthy adults. The result: NMN and NR both doubled circulating NAD+. No significant difference between them.

That settles a long-standing debate — at least for now. NMN is one enzymatic step closer to NAD+ in the biosynthetic pathway, which led some researchers to hypothesize it would be more efficient. The data says otherwise. Both work. Both also increased gut SCFAs, while nicotinamide did not.

The practical implication: choose based on dose, price, and how your body responds, not on theoretical biochemistry. If you're comparing multiple supplements for cognitive support or stress management, NMN and NR address a fundamentally different pathway (NAD+/sirtuin) than adaptogens or nootropics.

What About Anti-Aging?

The longevity narrative around NMN comes primarily from animal data, where it has extended healthspan and reversed certain aging markers in mice. Leading researcher Shin-ichiro Imai (Washington University) has stated NMN may improve adult metabolism to resemble someone 10 to 20 years younger, but cautions that human evidence is still early. The 2021 Yoshino trial (Science) confirmed NMN improves muscle insulin sensitivity in prediabetic women, but large-scale longevity trials in humans are not yet complete.

Shin-ichiro Imai, MD, PhD, a leading NMN researcher at Washington University, has publicly stated that NMN may improve adult human metabolism "to resemble that of someone ten to twenty years younger", though he has been careful to note this remains to be fully demonstrated in clinical settings (Shade, 2020, Integrative Medicine).

In humans, the evidence is more modest. Yi et al. (2023) found that biological age — measured via the Aging.Ai calculator, increased significantly in the placebo group over 60 days but stayed unchanged in all NMN-treated groups. Niu et al. reported that 300 mg/day nearly doubled telomere length in blood cells within 90 days, striking, but one small study.

We'll say it plainly: no human study has demonstrated that NMN extends lifespan. Anyone claiming NMN "reverses aging" is outpacing the science. What NMN may do is support healthier aging by maintaining NAD+ levels and slowing certain biomarkers of decline. That's not nothing, but it's not a fountain of youth either.

How much NMN did the trials use?

Human NMN trials used roughly 250 to 1,200 mg/day. The Yi (2023) RCT found 600 mg gave the best balance of NAD+ elevation and functional gains, with 900 mg adding little. Most people start near 250 to 300 mg to gauge tolerance, then hold a steady daily dose.

The most commonly studied dose is 250 mg/day, which raised NAD+ by 75% to sixfold across studies. According to Yi et al. (2023), clinical efficacy, measured by NAD+ levels and physical performance, peaked at 600 mg/day.

250 mg/day — Safe, well-studied. Showed improvements in gait speed, grip strength, and sleep quality across multiple trials. Most researchers consider this a reasonable starting point.

300 mg/day. Used in the Huang (2022) and Niu studies. Raised NAD+/NADH by 38% over 60 days.

600–900 mg/day. Greater NAD+ elevation and more pronounced walking distance improvements. No additional safety concerns. 600 mg appears to hit the optimal dose-response threshold based on current data.

1,000 mg/day — Used in the 2026 Christen et al. Nature Metabolism study. Doubled NAD+ in 14 days. Well tolerated over the study period.

Who Should Be Cautious with NMN

NMN has shown a strong safety profile across published trials, but it's not for everyone. Certain groups should consult a healthcare provider before starting NMN supplementation. If you're pregnant or nursing, there is zero human safety data in these populations, don't take the risk. If you're under 18, your NAD+ levels are likely already at their peak; supplementation is unnecessary.

If you're pregnant or nursing, there is zero human safety data in these populations, don't take the risk. If you're under 18, your NAD+ levels are likely already at their peak; supplementation is unnecessary. If you're taking medication for a chronic condition, particularly drugs metabolized through the same pathways (e.g., medications affecting NAD+ or sirtuin activity) — talk to your doctor first.

There's also an important nuance that most NMN marketing ignores: if you're healthy, under 40, eating well, exercising regularly, and sleeping enough, your NAD+ levels may not be meaningfully depleted. NMN's clinical benefits have been most clearly demonstrated in adults over 45 with measurable age-related decline.

Why We Chose to Carry NMN

We spent three months reviewing the NMN clinical trial field before deciding to add it to our lineup. The deciding factor wasn't the animal data or the longevity hype, it was the consistency of human safety data across 12+ published trials, combined with the January 2026 Nature Metabolism head-to-head comparison that settled the NMN vs. NR debate.

We were also persuaded by the dose-response data from Yi et al. (2023) showing that 600 mg/day hit the optimal efficacy threshold. We formulated our product to deliver a clinically relevant dose without requiring you to take a handful of capsules. Still, we're transparent about where the evidence stands. NMN reliably raises NAD+. The downstream functional benefits are encouraging but not definitive. We're not selling a miracle. We're selling a well-researched NAD+ precursor with a clean safety record, and we think that's worth something on its own.

For our full sourcing and testing standards, see our third-party lab results, the science behind our formulations, and our ingredient sourcing page.

See our NMN supplement for full dosage, ingredients, and third-party lab results.

Related Research

• PubMed: 27721479
• PubMed: 36476934
• PubMed: 27304511
• DOI: 10.1002/fft2.511
• PubMed: 34326206
• PubMed: 17086191
• PubMed: 21261636
• PubMed: 35927255
• PubMed: 20528005

Related Reading

• NMN And Resveratrol
• NMN Before And After
• NMN vs Nad

What's new in NMN research (2025–2026)?

By mid-2026, over 12 published human RCTs have tested NMN at doses between 250 mg and 1,250 mg/day. Across those trials, NAD+ blood levels consistently rise, and no serious adverse events have been flagged, though most protocols ran 12 weeks or less.

What NMN can and cannot do: setting evidence-based expectations

Human NMN trials have used 250–1,200 mg/day with blood NAD+ elevation confirmed across the range. The landmark Science trial (PMID: 33888596) used 250 mg/day; dose-response studies show NAD+ increases plateau around 600–900 mg. An evidence-based starting dose is 250–500 mg each morning — beyond that, cost rises faster than NAD+ does. For more on this topic, see our why people stop taking NMN guide.

What the evidence supports: NMN supplementation at 250 to 1,250 mg/day reliably raises blood NAD+ levels in humans. This is the most replicated finding across 12+ RCTs. NAD+ elevation peaks at about 2 to 4 hours post-dose and returns to near-baseline by 24 hours, which is why daily dosing is necessary to maintain elevated levels. Functional outcomes that have been measured in at least one well-designed RCT include improved aerobic capacity (walking speed, endurance metrics in older adults), enhanced muscle insulin sensitivity (Yoshino 2021), and modest improvements in sleep quality at higher doses.

What remains speculative but by mechanism plausible: anti-aging effects beyond biomarker changes, cognitive enhancement in healthy adults, cardiovascular protection, and immune function improvement. These are all supported by animal data and mechanistic reasoning (NAD+ is required for sirtuin activity, PARP-mediated DNA repair, and mitochondrial function), but human trials have not yet demonstrated these outcomes.

What is marketing exaggeration: claims that NMN "reverses aging," produces visible skin rejuvenation within weeks, replaces exercise, or functions as a weight loss supplement. No human trial has demonstrated any of these outcomes. The skin elasticity improvements reported in one trial (Yi 2023) were measured by instruments, not visible to the naked eye. For the comparison between NMN and its alternative NAD+ precursor, see NMN vs NR.

Which NMN benefits are actually proven?

The longevity supplement space is plagued by conflation of preclinical data with human evidence. Here is an honest tier ranking of NMN benefits based exclusively on published human RCTs. Tier 1 — Demonstrated in multiple human RCTs: Blood NAD+ elevation (12+ trials, consistent 40 to 100% increase depending on dose).

Tier 1 — Demonstrated in multiple human RCTs: Blood NAD+ elevation (12+ trials, consistent 40 to 100% increase depending on dose). This is the foundation, the mechanism that theoretically drives all downstream benefits. The question is whether raising NAD+ in the blood translates to meaningful tissue-level changes.

Tier 2. Demonstrated in at least one well-designed human RCT: Improved aerobic capacity in middle-aged adults (Kim 2022, 600 mg/day, 12 weeks). Improved muscle insulin sensitivity in postmenopausal prediabetic women (Yoshino 2021, 250 mg/day, 10 weeks). Improved skin elasticity by instrumental measurement (Yi 2023). These are real findings in real humans, but each comes from a single trial with modest sample size and short duration.

Tier 3 — Demonstrated in animal models but not yet in humans: Extended lifespan (Mills 2016, in mice). Reversed age-related arterial dysfunction (in mice). Restored fertility in aged mice. Improved cognitive function in aged mice. Reversed muscle wasting (in mice). The preclinical data is genuinely exciting, but the translation from mouse to human for longevity endpoints has historically been unreliable for most compounds.

Not demonstrated at any level: Weight loss. Visible skin rejuvenation. Hair regrowth or color restoration. Cancer prevention. Immune enhancement. Cognitive enhancement in healthy young adults. These are marketing claims without supporting evidence.

See NMN dosage for the protocols that produced the Tier 1 and 2 findings. See NMN vs NR for the precursor comparison. See longevity supplements for how NMN fits into the broader anti-aging evidence base.

Does NAD+ decline cause aging?

NMN dosing economics follow the trial data: 250 mg/day produced the landmark insulin-sensitivity result (PMID: 33888596), and dose-response work shows blood NAD+ gains flattening between 600–900 mg. The rational protocol starts at 250–500 mg each morning. Above 900 mg, you're buying NAD+ you largely can't use.

Observation 1: NAD+ levels decline by approximately 50% between ages 40 and 60 in human tissues (Massudi 2012). This decline is consistent across organs and populations.

Observation 2: NAD+ is required for sirtuin function (SIRT1 through SIRT7), PARP-mediated DNA repair, and CD38-mediated immune signaling, all of which decline with age in parallel with NAD+ levels.

Observation 3: Experimentally restoring NAD+ levels in aged mice (via NMN supplementation) reverses multiple age-associated functional declines: improved mitochondrial function (Gomes 2013), restored muscle function (Mills 2016), improved vascular function (Das 2018), and enhanced cognitive function (preclinical data).

Observation 4: Human NMN supplementation raises blood NAD+ levels by 40 to 100% and produces modest but measurable improvements in aerobic capacity, insulin sensitivity, and skin elasticity.

The gap: no human study has demonstrated that NMN supplementation extends lifespan, prevents age-related diseases, or reverses aging in a clinically meaningful way. The biomarker (NAD+) goes up; some functional markers improve modestly; but the leap from "raised NAD+" to "slower aging" remains unproven in humans. NMN supplementation is a bet on the causality of the NAD+ decline theory, a bet supported by strong preclinical data but unconfirmed in the species that matters most.

What does NMN probably do?

What NMN probably does (based on human RCT data): Raises blood NAD+ levels by 40 to 100%. Modestly improves aerobic exercise capacity in middle-aged adults. Improves muscle insulin sensitivity in metabolically impaired individuals. May slightly improve skin elasticity (detectable by instrument, not visible to the eye). May improve sleep quality through sirtuin-mediated circadian clock support.

What NMN might do (based on animal data not yet confirmed in humans): Slow aspects of biological aging through sustained sirtuin activation and DNA repair support. Improve vascular function and reduce arterial stiffness. Support cognitive function in aging through improved cerebral NAD+ availability. Enhance stem cell function and tissue regeneration capacity.

What NMN almost certainly does not do (no evidence at any level): Reverse visible aging (wrinkles, gray hair, age spots). Produce dramatic energy transformation. Cause weight loss. show anticancer activity in preclinical models. Replace healthy lifestyle habits (exercise, sleep, nutrition). Make you "feel 20 years younger."

The gap between "probably does" and "might do" is the space where NMN supplementation is a bet rather than a certainty. The ongoing longer-term trials (6 to 12 months) will narrow this gap. For now, NMN at 250 to 500 mg/day is a well-tolerated, reasonably-priced ($50 to $100/month) intervention that raises a biomarker consistently associated with aging. Whether that biomarker change produces the functional outcomes we hope for remains to be proven. See dosage and side effects.

For people deciding whether to start NMN: it is safe, raises NAD+ reliably, and has preliminary functional benefits. If the monthly cost is comfortable and longevity optimization interests you, 250 to 500 mg/day with morning breakfast is the evidence-aligned protocol. If budget is tight, prioritize creatine ($3/month), magnesium ($6/month), and vitamin D ($3/month) first — more established benefits at a fraction of the cost.

For the complete NMN decision toolkit: dosage protocols, safety profile, realistic expectations, NMN vs NR comparison, combination with resveratrol, and optimal timing.

What does the Kim (2022) exercise-capacity finding mean?

The Kim 2022 trial is particularly relevant for middle-aged adults who exercise regularly and have noticed a gradual decline in exercise capacity despite maintained training habits. The study administered 600 mg NMN daily to adults over 45 for 12 weeks and measured improvements in the 6-minute walk test, a validated measure of functional aerobic capacity that correlates with VO2 max.

The practical translation: participants could walk approximately 30 to 50 meters farther in 6 minutes after NMN supplementation versus placebo. This corresponds to roughly a 3 to 5% improvement in functional aerobic capacity, modest but meaningful for someone who has noticed that the same walking pace now feels harder than it did 5 years ago, or that recovery between exercise sets takes longer despite consistent training.

The proposed mechanism: NAD+ decline in aging muscle reduces mitochondrial ATP production efficiency, creating a progressive "energy ceiling" that limits exercise capacity independent of training status. NMN supplementation partially restores this mitochondrial capacity by replenishing the NAD+ substrate that the electron transport chain requires. This does not make you fitter than you were at 25. It partially restores the cellular energy infrastructure that aging has degraded.

The NMN evidence base continues to grow as new human trials publish results. The compound occupies a unique position in the longevity supplement space: better-evidenced than most anti-aging products, but still awaiting the longer-term human data that would move it from promising to proven.

“Clinical trials show increases in whole-blood NAD+ after NMN supplementation, which tells us the compound is biologically active and reaching its target. But translating that into healthy aging in humans is where the evidence becomes much less clear.”

Why YourHealthier NMN

The NAD+ restoration discussed in this article requires NMN that is what the label claims — purity matters because degraded or impure NMN produces less NAD+ per milligram. Our NMN provides 500 mg of nicotinamide mononucleotide per serving at ≥98% verified purity, third-party tested for identity, potency, and heavy metals. We publish batch-specific COAs on our Lab Results page because with a compound this expensive, you deserve to know exactly what you are paying for.

What Are NMN Benefits Specifically for Women?

NMN's core mechanism — boosting NAD+ levels to support cellular energy and DNA repair — operates identically in both sexes. However, several areas of NMN research hold particular relevance for women. NAD+ decline accelerates during perimenopause and menopause, coinciding with the drop in estrogen that normally supports mitochondrial function. Restoring NAD+ levels during this transition is a plausible (though not yet proven) strategy for mitigating age-related energy decline.

Animal studies have shown that NMN supplementation can improve oocyte quality in aged mice, which has generated interest in the fertility research community. Human data on this application does not yet exist. Skin aging is another area where NMN's NAD+ boosting effect may be relevant, since NAD+ supports sirtuin activity involved in DNA repair of UV-damaged skin cells. These remain areas of active research rather than established clinical benefits.

Are NMN Injections More Effective Than Oral Supplements?

NMN injections bypass the digestive system entirely, delivering the compound directly into the bloodstream or muscle tissue. In animal studies, injectable NMN produces rapid and significant increases in blood NAD+ levels. For human longevity clinics offering NMN injections (typically as subcutaneous or intramuscular shots), the rationale is higher bioavailability compared to oral capsules.

The catch is that injectable NMN is not FDA-approved for any indication, and the long-term safety of repeated NMN injections in humans has not been studied in controlled trials. Oral NMN has shown meaningful NAD+ increases in multiple published human studies, suggesting that the oral route — while potentially less efficient per milligram — is sufficient to produce measurable biological effects. For most people, oral NMN supplements remain the safer, more accessible, and better-studied option. NMN peptide formulations are not a distinct category — the term sometimes appears in marketing but refers to the same NMN molecule.

Frequently Asked Questions

Related Reading:

• How Long Does Ashwagandha Take to Work? The Honest Timeline
• Magnesium Glycinate Benefits: 7 Reasons It Beats Other Forms (2026)
• Berberine Benefits: What It Does for Blood Sugar, Metabolism, and More
• Lion's Mane Benefits: What This Mushroom Does for Your Brain and Body
• Ashwagandha and Cortisol: The Science Behind Stress Relief
• How Long Does Creatine Take to Work? The Science-Backed Timeline
• Best Mushroom Supplements of 2026: What to Look For (And What to Avoid)
• Magnesium Glycinate & Sleep: What NIH Research Shows (2026)
• Berberine Dosage: 500mg or 1500mg? Here's How to Start
• Is Berberine Safe Long-Term? 7 Risks Your Supplement Brand Won't Tell You
• Magnesium Glycinate for Sleep: Does It Actually Work?
• Ashwagandha Benefits: 7 Reasons It's the Most Popular Adaptogen
• KSM-66 vs Regular Ashwagandha: 24 Trials vs Zero — Your Call
• Lion's Mane Dosage: How Much Should You Take?
• Mushroom Coffee: What It Is, Benefits, and Is It Worth It?

Testing & Transparency Methodology

Every YourHealthier product referenced here is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories (ISO/IEC 17025, A2LA, or Eurofins, depending on the product). Each batch is screened for heavy metals (lead, cadmium, mercury, arsenic) and microbial contamination (total plate count, yeast, mold, E. coli, Salmonella) using validated USP, AOAC, and ICP-MS methods. Batch-specific certificates of analysis are published at yourhealthier.com/pages/lab-results and updated with each new manufacturing run. All testing complies with current Good Manufacturing Practices (21 CFR Part 111). This article is written for general educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

References

1. Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026;Jan 15. PubMed
2. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8:5. PubMed
3. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. GeroScience. 2023;45:29–43. PubMed
4. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372:1224–1229. PubMed
5. Huang H. A multicentre, randomised, double blind, parallel design, placebo controlled study to evaluate the efficacy and safety of Uthever (NMN supplement). Frontiers in Aging. 2022;3:851698. PubMed
6. Song Q, Zhou X, Xu K, et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Advances in Nutrition. 2023;14(6):1416–1435. PubMed
7. Zhang J, Poon ETC, Wong SHS. Efficacy of oral NMN supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis. Critical Reviews in Food Science and Nutrition. 2025;65(22):4382–4400. PubMed
8. Liao B, Zhao Y, Wang D, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. JISSN. 2021;18:54. PubMed
9. Yoshino J, Baur JA, Imai SI. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism. 2018;27:513–528. PubMed
10. Shade C. The science behind NMN, a stable, reliable NAD+ activator and anti-aging molecule. Integrative Medicine. 2020;19(1):12–14. PubMed
11. Katayoshi T, et al. Nicotinamide mononucleotide supplementation reduces arterial stiffness in healthy middle-aged adults. 2023.

Disclosure: YourHealthier sells NMN supplements. This article is written by our editorial team based on peer-reviewed research. We cite only published clinical trials and disclose where the evidence is limited. Our goal is to give you the information you need to make your own informed decision, not to pressure a purchase. See our Editorial Policy for how we research and write.

What is Nmn Good for?

NMN is a precursor to NAD+, a coenzyme essential for cellular energy, DNA repair, and sirtuin activation—processes that decline with age. A 2023 trial (PMID: 36482258) found 250 mg/day for 12 weeks raised blood NAD+ 38% and improved walking speed in older adults. The primary use is longevity support, most relevant for adults over 40.

What Does Nmn Mean?

NMN stands for nicotinamide mononucleotide, present in all living cells. It is a direct precursor to NAD+, a coenzyme essential for cellular energy, DNA repair, and sirtuin activation. NAD+ levels fall roughly 50% between ages 40 and 60, and NMN supplementation aims to restore them by supplying the building block. It was popularized by Harvard researcher Dr. David Sinclair.

What is Nmn Used for?

NMN is primarily used as an anti-aging supplement to replenish declining NAD+. Clinical findings include a 38% rise in blood NAD+ (PMID: 36482258), improved insulin sensitivity in prediabetic women (PMID: 33888596), and better walking endurance in older adults. Research is still emerging—most trials are small and short. Standard dose is 250–500 mg/day, most relevant for adults over 40.

Is Nmn a Peptide?

No. NMN (nicotinamide mononucleotide) is a nucleotide, not a peptide. Its formula is C₁₁H₁₅N₂O₈P. Peptides are chains of amino acids linked by peptide bonds; NMN is composed of a nicotinamide group, ribose sugar, and phosphate. It is a precursor to NAD+, a coenzyme—not a protein or peptide. This distinction matters for regulatory and sports-testing purposes: NMN is not a banned peptide.

Nmn Where to Buy

NMN supplements are available online from Amazon, iHerb, ProHealth Longevity, DoNotAge, and Alive By Science. In-store availability is limited—most pharmacies do not carry NMN given its niche market and higher price. Look for third-party testing for purity (>98% NMN) and stability. Sublingual tablets, capsules, and powder are all available. A 30-day supply at 500 mg/day typically costs $30–60.

Does Nmn Help with Weight Loss?

NMN is not a weight loss supplement. A 2021 trial (PMID: 33888596) found NMN improved insulin sensitivity in prediabetic women but reported no significant weight change. Its primary mechanism (NAD+ replenishment) supports cellular energy metabolism, but no trial has shown meaningful weight loss from NMN alone. For weight management, caloric deficit and exercise remain evidence-based.

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

NMN Benefits: What Trials Show

Metric	Value
Blood NAD+ rise (fold)	up to 6x
Time to double NAD+ (days)	14 days
NAD+ decline by age 60 (%)	~50%
Studied dose (mg/day)	250-1250
Source: YourHealthier · 12+ human trials; NAD+ powers 500+ reactions

Chart: NMN Benefits: What Trials Show. Data: Blood NAD+ rise (fold): up to 6x; Time to double NAD+ (days): 14 days; NAD+ decline by age 60 (%): ~50%; Studied dose (mg/day): 250-1250. Source: 12+ human trials; NAD+ powers 500+ reactions.